Breast cancer gene test alarm over UK insurance
This article was originally published in Clinica
Executive Summary
The Association of British Insurers (ABI) has denied reports that it is seeking to prematurely break its voluntary code on the use of genetic test results for actuarial purposes by excluding breast cancer. "No such application has been made or is planned," the ABI told Clinica.